Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows:
- generic, OTC and biosimilar drugs (48.3%);
- patented prescription products (37.3%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments;
- pharmaceutical ingredients and outsourcing services (7.2%) ;
- animal products (7%);
- other (0.2%).
Net sales are distributed geographically as follows: Finland (30.3%), Scandinavia (13.6%), Europe (34%), North America (8.6%) and other (13.5%).
More about the company